Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,039 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

Assessment of Macrophage Activation syndromE in STill's Disease

NCT06405152

Conditions
Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, +12 more
Locations
  • Swedish Orphan Biovitrum Research Site Los Angeles, California, United States
  • Swedish Orphan Biovitrum Research Site Atlanta, Georgia, United States
  • Swedish Orphan Biovitrum Research Site Cincinnati, Ohio, United States
  • Swedish Orphan Biovitrum Research Site Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

NCT03340766

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Charleston, South Carolina, United States
  • Research Site Greenville, South Carolina, United States
  • Research Site Darlinghurst, New South Wales, Australia
View all 22 locations
View Trial Details
Completed

Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL

NCT04134936

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • MorphoSys Research Site Tucson, Arizona, United States
  • MorphoSys Research Site Anaheim, California, United States
  • MorphoSys Research Site Duarte, California, United States
  • MorphoSys Research Site Encinitas, California, United States
View all 70 locations
View Trial Details

Related conditions